The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ANI Pharmaceuticals Inc shares valued at $1,268,800 were sold by Gassert Chad on Jul 01 ’24. At $63.44 per share, Gassert Chad sold 20,000 shares. The insider’s holdings dropped to 193,226 shares worth approximately $11.75 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Shanmugam Muthusamy sold 20,000 shares, netting a total of over 1,178,000 in proceeds. Following the sale of shares at $58.90 each, the insider now holds 682,620 shares.
Before that, Shanmugam Muthusamy had sold 11,447 shares from its account. In a trade valued at $685,217, the HEAD OF R&D, COO-NOVITIUM OPS traded ANI Pharmaceuticals Inc shares for $59.86 each. Upon closing the transaction, the insider’s holdings decreased to 11,447 shares, worth approximately $42.73 million.
As published in their initiating research note from CapitalOne on March 15, 2024, ANI Pharmaceuticals Inc [ANIP] has been an Overweight and the price target has been revised to $80. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in late August. As of March 01, 2023, Guggenheim has initiated its “Buy” rating for ANIP. Earlier on September 07, 2022, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ANIP stock.
Analyzing ANIP Stock Performance
During the last five days, there has been a drop of approximately -7.13%. Over the course of the year, ANI Pharmaceuticals Inc shares have jumped approximately 10.30%. Shares of the company reached a 52-week high of $70.81 on 03/25/24 and a 52-week low of $53.47 on 01/16/24. A 50-day SMA is recorded $64.20, while a 200-day SMA reached $60.12. Nevertheless, trading volume fell to 81887.0 shares from 0.15 million shares the previous day.
Support And Resistance Levels for ANI Pharmaceuticals Inc (ANIP)
According to the 24-hour chart, there is a support level at 60.17, which, if violated, would cause prices to drop to 59.52. In the upper region, resistance lies at 61.94. The next price resistance is at 63.06. RSI (Relative Strength Index) is 42.35 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.02, which suggests the price will decrease in the coming days. Percent R is at 68.01%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
